GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Cell Impact (OSTO:CI) » Definitions » Forward PE Ratio

Cell Impact (OSTO:CI) Forward PE Ratio : 0.00 (As of Jun. 03, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cell Impact Forward PE Ratio?

Cell Impact's Forward PE Ratio for today is 0.00.

Cell Impact's PE Ratio without NRI for today is 0.00.

Cell Impact's PE Ratio for today is 0.00.


Cell Impact Forward PE Ratio Historical Data

The historical data trend for Cell Impact's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cell Impact Forward PE Ratio Chart

Cell Impact Annual Data
Trend
Forward PE Ratio

Cell Impact Quarterly Data
Forward PE Ratio

Competitive Comparison of Cell Impact's Forward PE Ratio

For the Metal Fabrication subindustry, Cell Impact's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Impact's Forward PE Ratio Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Cell Impact's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Cell Impact's Forward PE Ratio falls into.



Cell Impact Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Cell Impact  (OSTO:CI) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Cell Impact Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Cell Impact's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cell Impact (OSTO:CI) Business Description

Traded in Other Exchanges
Address
Kallmossvagen 7A, Karlskoga, SWE, 691 52
Cell Impact develops technologies to produce flow plates for fuel cells. It provides graphite, stainless steel, and titanium flow plates. The company has developed and patented a unique method for high-velocity forming, Cell Impact Forming that makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional molding methods.

Cell Impact (OSTO:CI) Headlines

From GuruFocus

Q3 2022 Cigna Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Cigna Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Cigna Group at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Q2 2023 Cigna Group Earnings Call Transcript

By GuruFocus Research 01-22-2024

Cigna Corp Investor Day Transcript

By GuruFocus Research 01-22-2024

Q1 2022 Cigna Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Cigna Corp at Cowen Health Care Conference Transcript

By GuruFocus Research 01-22-2024